A detailed history of Tounjian Advisory Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Tounjian Advisory Partners, LLC holds 15,492 shares of BSX stock, worth $1.59 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
15,492
Holding current value
$1.59 Million
% of portfolio
0.5%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$94.95 - $104.98 $1.47 Million - $1.63 Million
15,492 New
15,492 $1.48 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Tounjian Advisory Partners, LLC Portfolio

Follow Tounjian Advisory Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tounjian Advisory Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tounjian Advisory Partners, LLC with notifications on news.